Terms: = Ovarian cancer AND ELK4, SAP1, 2005, ENSG00000158711, P28324 AND Treatment
350 results:
1. Agricultural exposure and risk of ovarian cancer in the AGRIculture and cancer (AGRICAN) cohort.
Renier M; Hippert J; Louis-Bastien W; Tual S; Meryet-Figuiere M; Vigneron N; Marcotullio E; Baldi I; Lebailly P;
Occup Environ Med; 2024 Feb; 81(2):75-83. PubMed ID: 38199811
[TBL] [Abstract] [Full Text] [Related]
2. Significance of Ultra-Radical Surgery in Extensive Metastatic ovarian Growing Teratoma Syndrome.
Li S; Wang T; Du H; Tang H; Zhang T; Zhang R; Zhang X; Yang J
Oncology; 2023; 101(12):773-781. PubMed ID: 38096801
[TBL] [Abstract] [Full Text] [Related]
3. Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
Thomsen MK; Løppenthin KB; Bidstrup PE; Andersen EW; Dalton S; Petersen LN; Pappot H; Mortensen CE; Christensen MB; Frølich A; Lassen U; Johansen C
Acta Oncol; 2023 Dec; 62(12):1653-1660. PubMed ID: 37874076
[TBL] [Abstract] [Full Text] [Related]
4. High serum levels of inflammatory markers are associated with early recurrence in patients with high-grade serous ovarian cancer after platinum therapy.
Brzezinska B; Mysona DP; Richardson KP; Rungruang B; Hopkins D; Bearden G; Higgins R; Johnson M; Satter KB; McIndoe R; Ghamande S; Purohit S
Gynecol Oncol; 2023 Dec; 179():1-8. PubMed ID: 37862814
[TBL] [Abstract] [Full Text] [Related]
5. Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Singh N; Manchanda R; Kalsi JK; Woolas R; Arora R; Casey L; Dawnay A; Sharma A; Williamson K; Apostolidou S; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Jacobs IJ; Parmar MKB
Lancet Oncol; 2023 Sep; 24(9):1018-1028. PubMed ID: 37657461
[TBL] [Abstract] [Full Text] [Related]
6. Stereotactic Body Reirradiation in Gynaecological cancer: Outcomes and Toxicities from a Single Institution Experience.
Macchia G; Pezzulla D; Cilla S; Buwenge M; Romano C; Ferro M; Boccardi M; Ferioli M; Bonome P; Lancellotta V; Tagliaferri L; Ferrandina G; Gambacorta MA; Morganti AG; Deodato F
Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):682-693. PubMed ID: 37558548
[TBL] [Abstract] [Full Text] [Related]
7. Genetic analysis for mucinous ovarian carcinoma with infiltrative and expansile invasion and mucinous borderline tumor: a retrospective analysis.
Hada T; Miyamoto M; Ohtsuka Y; Suminokura J; Ito T; Kishimoto N; Nishitani S; Takada M; Imauji A; Tanabe R; Takano M
Diagn Pathol; 2023 Apr; 18(1):49. PubMed ID: 37081552
[TBL] [Abstract] [Full Text] [Related]
8. Clinical calculator redefines prognosis for high-risk early-stage ovarian cancers and potential to guide treatment in the adjuvant setting.
Bui A; Gehrig PA; Ghamande S; Rungruang BJ; Chan JK; Mysona DP
Gynecol Oncol; 2022 Nov; 167(2):205-212. PubMed ID: 36055814
[TBL] [Abstract] [Full Text] [Related]
9. [treatment Outcome of Ureteral Reconstruction Surgery].
Miyauchi K; Wada N; Nagabuchi M; Ishikawa M; Makino S; Abe N; Hori JI; Tamaki G; Tateoka J; Kita M; Kakizaki H
Hinyokika Kiyo; 2022 Jul; 68(7):227-231. PubMed ID: 35924705
[TBL] [Abstract] [Full Text] [Related]
10. Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced ovarian/Tubal/Peritoneal cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.
Copeland LJ; Brady MF; Burger RA; Rodgers WH; Huang HQ; Cella D; O'Malley DM; Street DG; Tewari KS; Bender DP; Morris RT; Lowery WJ; Miller DS; Dewdney SB; Spirtos NM; Lele SB; Guntupalli S; Ueland FR; Glaser GE; Mannel RS; DiSaia PJ
J Clin Oncol; 2022 Dec; 40(35):4119-4128. PubMed ID: 35759733
[TBL] [Abstract] [Full Text] [Related]
11. Utilization and Outcomes of Sentinel Lymph Node Biopsy for Early Endometrial cancer.
Matsuo K; Klar M; Nusbaum DJ; Hasanov MF; Vallejo A; Ciesielski KM; Muderspach LI; Roman LD; Wright JD
Obstet Gynecol; 2022 May; 139(5):809-820. PubMed ID: 35576340
[TBL] [Abstract] [Full Text] [Related]
12. Hereditary breast cancer and fertility preservation outcomes.
Arab S; Tulandi T; Buckett W
J Assist Reprod Genet; 2022 May; 39(5):1163-1168. PubMed ID: 35403930
[TBL] [Abstract] [Full Text] [Related]
13. treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients.
Sivakumaran T; Krasovitsky M; Freimund A; Lee YC; Webber K; So J; Norris C; Friedlander M; Mileshkin L; Au-Yeung G
Int J Gynecol Cancer; 2022 Jul; 32(7):906-912. PubMed ID: 35321889
[TBL] [Abstract] [Full Text] [Related]
14. Ultrasonographic diagnosis and surgical outcomes of adnexal masses in children and adolescents.
Kang GG; So KA; Hwang JY; Kim NR; Yang EJ; Shim SH; Lee SJ; Kim TJ
Sci Rep; 2022 Mar; 12(1):3949. PubMed ID: 35273292
[TBL] [Abstract] [Full Text] [Related]
15. Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors.
Zhou B; Kwan B; Desai MJ; Nalawade V; Ruddy KJ; Nathan PC; Henk HJ; Murphy JD; Whitcomb BW; Su HI
Fertil Steril; 2022 May; 117(5):1047-1056. PubMed ID: 35216831
[TBL] [Abstract] [Full Text] [Related]
16. The role of PARP inhibitors in gastrointestinal cancers.
Hanna D; Chopra N; Hochhauser D; Khan K
Crit Rev Oncol Hematol; 2022 Mar; 171():103621. PubMed ID: 35124199
[TBL] [Abstract] [Full Text] [Related]
17. ovarian cancer surgery in Germany: An analysis of the nationwide hospital file 2005-2015.
Trocchi P; Mach P; Kimmig KR; Stang A
Womens Health (Lond); 2022; 18():17455065221075903. PubMed ID: 35114854
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy of dexamethasone in the management of malignant small bowel obstruction in advanced epithelial ovarian cancer.
Jones APM; McGauran MFG; Jagasia N; Hiscock RJ; Hyde S; Grant P
Support Care Cancer; 2022 Mar; 30(3):2821-2827. PubMed ID: 34846570
[TBL] [Abstract] [Full Text] [Related]
19. The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
Ou YC; Fu HC; Lan J; Wu CH; Kung FT; Lan KC; Tsai YC; Lin H
Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():99-104. PubMed ID: 34739876
[TBL] [Abstract] [Full Text] [Related]
20. Incidence, treatment, and survival trends in older versus younger women with epithelial ovarian cancer from 2005 to 2018: A nationwide Danish study.
Ekmann-Gade AW; Høgdall CK; Seibæk L; Noer MC; Fagö-Olsen CL; Schnack TH
Gynecol Oncol; 2022 Jan; 164(1):120-128. PubMed ID: 34716025
[TBL] [Abstract] [Full Text] [Related]
[Next]
